Anti-PI 3 Kinase catalytic subunit gamma/PI3K-gamma antibody [EPR25156-60] (Ab302958)

PI3-kinase subunit gamma, PI3K-gamma, PI3Kgamma, PtdIns-3-kinase subunit gamma, Phosphoinositide-3-kinase catalytic gamma polypeptide, Serine/threonine protein kinase PIK3CG, p120-PI3K, PtdIns-3-kinase subunit p110-gamma, p110gamma, PIK3CG

反应种属:Human, Mouse, Rat
抗原名称:PIK3CG
应用:WB, IHC, IP

详细信息

免疫原The exact immunogen used to generate this antibody is proprietary information.
宿主/亚型Rabbit / IgG
抗体类型Monoclonal
产品形式Liquid
纯化方式Affinity purification Protein A
储存缓冲液pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
储存条件运输条件: Conditional Ambient 推荐的短期储存时间: 1-2 weeks 推荐的短期储存条件: +4°C 推荐的长期储存条件: -20°C 储存信息: Avoid freeze / thaw cycle
无载体蛋白No

背景信息

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.

文献引用 (90)

Aminated fullerene-based nanoplatform enables synergistic VEGFR2-targeted anti-angiogenesis and tumor immunotherapy.

基于氨基化富勒烯的纳米平台可实现协同的 VEGFR2 靶向抗血管生成和肿瘤免疫治疗。

Huo Jiawei, Wang Yijun, Liu Lei, Li Jie, Yang Libin, Wang Zehu, Li Bowen, Zhang Weixin, Wang Xin, Siringan Mark John, Li Xue, Zhao Ruili, Huang Dongling, Liao Wanwen, Wang Chunru, Bai Chunli

PD-1 blockade promotes mucosal CD4+ T cell IL-10 production through altering microbiota to reduce intestinal ischemia reperfusion injury.

PD-1阻断通过改变微生物群促进粘膜CD4+ T细胞IL-10的产生,从而减少肠道缺血再灌注损伤。

Wen Shi-Hong, Zhang Yi-Nan, Shen Jian-Tong, Guo Yi, Chang Ze-Nan, Zhang Hu-Fei, Liu Zi-Meng, Zhang Xu-Yu

The mechanisms by which hypothalamic neuroinflammation induced by neonatal cerebral ischemia-hypoxia leads to decreased thymic function via the HPA axis.

新生儿脑缺血缺氧引起的下丘脑神经炎症通过HPA轴导致胸腺功能下降的机制。

Liu Gai-Gai, Shuang Li-Yan, Zhang Qian, Su Guang-Jun, Huang Yun, Xue Jin-Hua, Jiang Li-Xia, Huang Cheng, Chen Tao, Huang Zhi-Hua, Cao Si

LYVE-1 identifies asthma and drives PDGF-BB-induced proliferation, migration, and oxidative stress in airway smooth muscle cells via the PI3K/Akt pathway.

LYVE-1 可识别哮喘,并通过 PI3K/Akt 通路驱动 PDGF-BB 诱导的气道平滑肌细胞增殖、迁移和氧化应激。

Tang Yunbo, Zhou Nan, Ni Xiaohui

Alpha-Fetoprotein Stimulates Cleavage of Membranal MICA/B on Liver Cancer Cell Lead to Escape Immune Surveillance of Natural Killer Cells.

甲胎蛋白刺激肝癌细胞膜上MICA/B的裂解,导致其逃避自然杀伤细胞的免疫监视。

Li Xiaowei, Feng Siren, Wu Xueqin, Pan Yinglian, Zhou Yuli, Liu Kun, Lin Bo, Li Wei, Li Mengsen, Zhu Mingyue

COL8A1 promotes prostate cancer progression via modulating tumor immune infiltration and activating the FAK/PI3K/AKT pathway through ADAMTS2 regulation.

COL8A1 通过调节肿瘤免疫浸润和激活 FAK/PI3K/AKT 通路来促进前列腺癌的进展,而激活通路是通过 ADAMTS2 调控实现的。

Wang Jinrun, Ning Jinzhuo, Xu Lizhe, Cheng Fan

Ginsenoside Rb1 alleviates endothelial dysfunction and vascular remodeling in preeclampsia via activation of the PI3K-Akt-eNOS pathway.

人参皂苷 Rb1 通过激活 PI3K-Akt-eNOS 通路缓解先兆子痫中的内皮功能障碍和血管重塑。

Jia Wen, Wang Wenli, Zhang Baolian, Wang Chengshu, Huang Xianghua

Intervention of Rutin and Ochnaflavone in the Attenuation of Neuroinflammation and Neuronal Apoptosis in Spinal Cord Injury.

芦丁和金盏花酮在脊髓损伤中减轻神经炎症和神经元凋亡的作用。

Yu Tao, Yang Xuhao, Dai Anyuan, Yun Zhihe, Xue Wu, Yuan Tianyang, Nie Xinyu, Han Inbo, Liu Yanting, Wang A O, Liu Qinyi

TMB-related immune gene PAEP influences clear cell renal cell carcinoma progression and prognosis

TMB相关免疫基因PAEP影响透明细胞肾细胞癌的进展和预后

Jie Yang,Guoliang Wu,Qian Wu,Xinming Hu,Zechun Peng,Dan Zhang,Shuming He

RAB25 promotes hepatitis B virus-induced liver fibrosis progression through activation of the PI3K/AKT signaling pathway.

RAB25 通过激活 PI3K/AKT 信号通路促进乙型肝炎病毒引起的肝纤维化进展。

Liu Jing, Liu Bingjie, Xie Xia, Yang Xin, Liu Qiong
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 9